Literature DB >> 12617676

Palladium catalyzed kinetic and dynamic kinetic asymmetric transformations of gamma-acyloxybutenolides. Enantioselective total synthesis of (+)-Aflatoxin B1 and B2a.

Barry M Trost1, F Dean Toste.   

Abstract

The reaction of gamma-tert-butoxycarbonyloxy-2-butenolide with phenol nucleophiles in the presence of a Pd(0) complex with chiral ligands may be performed under conditions that favor either a kinetic resolution or a kinetic asymmetric transformation (KAT) or dynamic kinetic asymmetric transformation (DYKAT). Performing the reaction at high concentration (0.5 M) in the presence of a carbonate base favors the former, i.e., KAT; whereas, running the reaction at 0.1M in the presence of tetra-n-butylammonium chloride favors the DYKAT process. Syntheses of aflatoxin B(1) and B(2a) employs the DYKAT to introduce the stereochemistry. Starting with Pechmann condensation of the monomethyl ether of phloroglucinol, the requisite phenol nucleophile is constructed in two steps. The DYKAT proceeds with > 95% ee. A reductive Heck cyclization followed by a lanthanide catalyzed intramolecular acylation completes the synthesis of the pentacyclic nucleus in 3 steps. Reduction of the lactone provides aflatoxin B(2a) and its dehydration product B(1). This synthetic strategy creates an asymmetric synthesis of the former in only 7 steps and the latter in 9 steps. Thus, the ultimate synthetic sequence involves 3 + 5 --> 39 --> 40 --> 42 --> 43 --> 46 --> 47 --> 48 (aflatoxin B(2a)) --> 49 (aflatoxin B(1)).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12617676     DOI: 10.1021/ja020988s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  10 in total

1.  Pd and Mo Catalyzed Asymmetric Allylic Alkylation.

Authors:  Barry M Trost
Journal:  Org Process Res Dev       Date:  2012-01-13       Impact factor: 3.317

2.  Enantioselective Intramolecular Allylic Substitution via Synergistic Palladium/Chiral Phosphoric Acid Catalysis: Insight into Stereoinduction through Statistical Modeling.

Authors:  Cheng-Che Tsai; Christopher Sandford; Tao Wu; Buyun Chen; Matthew S Sigman; F Dean Toste
Journal:  Angew Chem Int Ed Engl       Date:  2020-06-30       Impact factor: 15.336

Review 3.  Catalytic Asymmetric Synthesis of Butenolides and Butyrolactones.

Authors:  Bin Mao; Martín Fañanás-Mastral; Ben L Feringa
Journal:  Chem Rev       Date:  2017-06-22       Impact factor: 60.622

4.  Acid-mediated coupling of γ-hydroxybutenolides and aldehydes: Synthesis of a new class of spirocyclic ketal-lactones.

Authors:  Alberto Munoz; Ryan P Murelli
Journal:  Tetrahedron Lett       Date:  2012-10-12       Impact factor: 2.415

5.  Novel aflatoxin derivatives and protein conjugates.

Authors:  Christian Cervino; Dietmar Knopp; Michael G Weller; Reinhard Niessner
Journal:  Molecules       Date:  2007-03-27       Impact factor: 4.411

6.  Asymmetric total synthesis of the iridoid beta-glucoside (+)-geniposide via phosphine organocatalysis.

Authors:  Regan A Jones; Michael J Krische
Journal:  Org Lett       Date:  2009-04-16       Impact factor: 6.005

7.  Asymmetric synthesis of chiral cycloalkenone derivatives via palladium catalysis.

Authors:  Barry M Trost; James T Masters; Jean-Philip Lumb; Dahlia Fateen
Journal:  Chem Sci       Date:  2014-04-01       Impact factor: 9.825

8.  Pd- η3 -C6H9 complexes of the Trost modular ligand: high nuclearity columnar aggregation controlled by concentration, solvent and counterion.

Authors:  Daugirdas Tomas Racys; Julian Eastoe; Per-Ola Norrby; Isabelle Grillo; Sarah E Rogers; Guy C Lloyd-Jones
Journal:  Chem Sci       Date:  2015-07-15       Impact factor: 9.825

9.  Catalytic asymmetric synthesis of geminal-dicarboxylates.

Authors:  Nisha Mistry; Stephen P Fletcher
Journal:  Chem Sci       Date:  2018-06-28       Impact factor: 9.825

Review 10.  Advances in the Total Synthesis of Aflatoxins.

Authors:  Liyan Yang; Zhonglei Wang
Journal:  Front Chem       Date:  2021-11-30       Impact factor: 5.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.